Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAM | P19021 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CTH | P32929 | 1/20 | 0.33 |
| ▸ | CBS | P35520 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | TTR | P02766 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2909899 | 0.91 | PAM (0.40) | PAMKMT2ANPC1MEN1ALDH1A1 | |
| SCHEMBL887066 | 0.88 | PAM (0.39) | PAMKMT2ANPC1MEN1ALDH1A1 | |
| SCHEMBL4261273 | 0.84 | PAM (0.42) | PAMALDH1A1TDP1TSHRCTH | |
| SCHEMBL18799223 | 0.82 | MGAM (0.48) | ALDH1A1LMNATSHR | |
| SCHEMBL10591606 | 0.79 | MGAM (0.50) | ALDH1A1LMNATSHR | |
| SCHEMBL2600796 | 0.78 | PAM (0.41) | PAMTSHRCTHCBSTHPO | |
| SCHEMBL2617512 | 0.78 | PAM (0.38) | PAM | |
| SCHEMBL11713191 | 0.77 | PAM (0.44) | PAMALDH1A1TDP1TSHRCTH | |
| SCHEMBL260254 | 0.77 | PAM (0.37) | PAM | |
| SCHEMBL2750378 | 0.76 | TSHR (0.43) | KMT2ANPC1MEN1ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2023-10-19 | — | — | US | disclosed |
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | COLOROBBIA ITALIA S.P.A. (IT) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331850-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | PAM 88/4885KMT2A 760/4885NPC1 3684/4885 |
| US-20230330273-A1 | MAGNETIC NANOPARTICLES FUNCTIONALIZED WITH CATHECOL, PRODUCTION AND USE THEREOF | CD47, CD14, COMT | PAM 88/4885KMT2A 760/4885NPC1 3684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.